Xinyi Tu
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
-
- DNA Repair Mechanisms 13
- Ubiquitin and proteasome pathways 5
- Advanced biosensing and bioanalysis techniques 5
- CRISPR and Genetic Engineering 4
- RNA Interference and Gene Delivery 3
- Oncology 14
- PARP inhibition in cancer therapy 5
- Cancer-related Molecular Pathways 4
- Co-authors
- Zhenkun Lou (21 shared papers)Somaira Nowsheen (8 shared papers)Jia Yu (5 shared papers)Bo Qin (6 shared papers)Jian Yuan (7 shared papers)Liewei Wang (6 shared papers)Qin Zhou (11 shared papers)Ping Yin (10 shared papers)
- Journals
- Nature Communications (5 papers)Molecular Cell (3 papers)Cell Research (2 papers)Nano Letters (1 paper)Nucleic Acids Research (1 paper)
- Partner nations
- United StatesChinaHong Kong
In The Last Decade
Xinyi Tu
33 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 80
- Oncology 392
- Immunology 202
- Molecular Biology 612
- Cancer Research 112
- Cell Biology 72
Countries citing papers authored by Xinyi Tu
This map shows the geographic impact of Xinyi Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinyi Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinyi Tu more than expected).
Fields of papers citing papers by Xinyi Tu
This network shows the impact of papers produced by Xinyi Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinyi Tu. The network helps show where Xinyi Tu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xinyi Tu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 195 | |
| 2 | 2019 | 134 | |
| 3 | 2018 | 75 | |
| 4 | 2020 | 74 | |
| 5 | 2018 | 71 | |
| 6 | 2015 | 70 | |
| 7 | 2020 | 50 | |
| 8 | 2022 | 46 | |
| 9 | 2020 | 43 | |
| 10 | 2019 | 41 | |
| 11 | 2021 | 38 | |
| 12 | 2021 | 31 | |
| 13 | 2020 | 28 | |
| 14 | 2023 | 23 | |
| 15 | 2021 | 20 | |
| 16 | 2021 | 18 | |
| 17 | 2021 | 12 | |
| 18 | 2023 | 12 | |
| 19 | 2023 | 9 | |
| 20 | 2021 | 9 |
About Xinyi Tu
Xinyi Tu is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Surgery, having authored 39 papers that have together received 1.0k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (13 papers), Ubiquitin and proteasome pathways (5 papers), PARP inhibition in cancer therapy (5 papers), Advanced biosensing and bioanalysis techniques (5 papers), Cancer-related Molecular Pathways (4 papers), interferon and immune responses (4 papers), CRISPR and Genetic Engineering (4 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Oncology (392 citations), Immunology (202 citations), Molecular Biology (612 citations), Cancer Research (112 citations) and Cell Biology (72 citations). Xinyi Tu has collaborated with scholars based in United States, China and Hong Kong. Frequent co-authors include Zhenkun Lou, Somaira Nowsheen, Jia Yu, Bo Qin, Jian Yuan, Liewei Wang, Qin Zhou, Ping Yin, Fei Zhao and Kuntian Luo. Their work appears in journals such as Nature Communications, Molecular Cell, Cell Research, Nano Letters and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.